BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38122884)

  • 21. Enhanced antitumor efficacy of glutathione-responsive chitosan based nanoparticles through co-delivery of chemotherapeutics, genes, and immune agents.
    Zhang L; Li Q; Chen J; Tang C; Yin C
    Carbohydr Polym; 2021 Oct; 270():118384. PubMed ID: 34364626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
    Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
    Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
    Yu B; Tang C; Yin C
    Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction-Triggered Paclitaxel Release Nano-Hybrid System Based on Core-Crosslinked Polymer Dots with a pH-Responsive Shell-Cleavable Colorimetric Biosensor.
    Kim SG; Ryplida B; Phuong PTM; Won HJ; Lee G; Bhang SH; Park SY
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer gene therapy mediated by RALA/plasmid DNA vectors: Nitrogen to phosphate groups ratio (N/P) as a tool for tunable transfection efficiency and apoptosis.
    Neves AR; Sousa A; Faria R; Albuquerque T; Queiroz JA; Costa D
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110610. PubMed ID: 31711736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
    Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
    Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
    Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
    Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.
    Xue J; Li R; Gao D; Chen F; Xie H
    Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
    Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
    Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells.
    Egorova A; Selutin A; Maretina M; Selkov S; Kiselev A
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.
    Li X; Qin F; Yang L; Mo L; Li L; Hou L
    Int J Nanomedicine; 2014; 9():3971-85. PubMed ID: 25170267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
    Cherukula K; Uthaman S; Park IK
    Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
    Yang X; Cai X; Yu A; Xi Y; Zhai G
    J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.